Wysota Christina N, Henriksen Lisa, Romm Katelyn F, Duan Zongshuan, Wang Yan, Huang Jidong, Berg Carla J
Department of Prevention and Community Health, Milken Institute School of Public Health, George Washington University, Washington, District of Columbia, USA.
Department of Medicine, Stanford Prevention Research Center, Stanford University School of Medicine, Palo Alto, California, USA.
Cannabis Cannabinoid Res. 2023 Dec;8(6):1140-1149. doi: 10.1089/can.2022.0029. Epub 2022 Jul 26.
Cannabidiol (CBD) has gained popularity in the United States, particularly among certain populations, including young adults. Thus, we examined (1) CBD product knowledge, perceptions, use, and use intentions among young adults and (2) correlates of use and use intentions. We analyzed data from a Fall 2020 survey regarding tobacco and other substance use among 2464 young adults in 6 U.S. cities (M=24.67; 57.4% female; 28.7% racial/ethnic minority). We used multinomial regression to identify correlates of use status (i.e., former [ever but no past 6 months] use vs. current [past 6 months] and never use, respectively), and linear regression to examine use intentions among never users. Around 51.4% reported ever use, and 32.0% reported current use. On average, participants perceived CBD as safe and effective for addressing pain, anxiety, and sleep (also prominent use motives: ∼40% to 60%, respectively). Use intentions were relatively high, particularly for edibles and topicals (also the most common use modes). Roughly one-fourth mistakenly believed that CBD products were required to be approved by U.S. Food and Drug Administration (24.9%), tested/proven safe (28.8%), and proven effective to be marketed for pain, anxiety, sleep, and so on. (27.2%). Compared to former users, never users perceived greater CBD-related risk (<0.001), less social acceptability (<0.001), and greater difficulty accessing CBD (=0.004); current users perceived more health benefits (<0.001). Among never users, greater use intentions were associated with greater perceived social acceptability (<0.001), health benefits (<0.001), and difficulty accessing CBD (=0.005). Given misperceptions about CBD, surveillance of young adults' knowledge, perceptions, and use of CBD is critical as its market expands.
大麻二酚（CBD）在美国越来越受欢迎，尤其是在包括年轻人在内的某些人群中。因此，我们研究了（1）年轻人对CBD产品的了解、认知、使用情况及使用意愿，以及（2）使用情况和使用意愿的相关因素。我们分析了2020年秋季一项关于美国6个城市2464名年轻人烟草及其他物质使用情况的调查数据（平均年龄M = 24.67岁；女性占57.4%；少数族裔占28.7%）。我们使用多项回归来确定使用状态的相关因素（即曾经使用过[过去使用过但过去6个月未使用]与当前使用[过去6个月内使用]及从未使用的情况），并使用线性回归来研究从未使用者的使用意愿。约51.4%的人报告曾经使用过，32.0%的人报告当前正在使用。平均而言，参与者认为CBD在缓解疼痛、焦虑和睡眠方面是安全有效的（也是主要的使用动机：分别约为40%至60%）。使用意愿相对较高，尤其是对于食用产品和外用产品（也是最常见的使用方式）。约四分之一的人错误地认为CBD产品需要获得美国食品药品监督管理局的批准（24.9%）、经过测试/证明是安全的（28.8%）以及证明对疼痛、焦虑、睡眠等有效才能上市销售（27.2%）。与曾经使用者相比，从未使用者认为CBD相关风险更高（<0.001）、社会接受度更低（<0.001）且获取CBD的难度更大（=0.004）；当前使用者认为其对健康更有益（<0.001）。在从未使用者中，更高的使用意愿与更高的社会接受度（<0.001）、健康益处（<0.001）以及获取CBD的难度更大（=0.005）相关。鉴于对CBD存在误解，随着其市场的扩大，对年轻人关于CBD的知识、认知和使用情况进行监测至关重要。
